User:Natureium/experimental cancer drugs

List

Non-FDA approved anti-neoplastic drugs
 * Priority small molecule inhibitors and monoclonal antibodies
 * *FDA approved, but investigated for other indications

• A

• Abagovomab

• Abemaciclib

• Abituzumab

• ADH-1

• AI-10-49

• Alvocidib

• Apalutamide

• Apatinib

• Avelumab

• B

• Bavituximab

• BI811283

• Binimetinib

• Bivatuzumab mertansine

• Brigatinib

• Brivanib alaninate

• Buparlisib

• D

• Dacomitinib

• Dactolisib

• Depatuxizumab mafodotin

• Darolutamide

• Dusigitumab

• E

• Enfortumab vedotin

• Eptinezumab

• Erenumab

• F

• Filanesib

• Futuximab

• I

• Ibrutinib*

• L

• Lilotomab

• Lorvotuzumab mertansine

• Luminespib

• O

• Ombrabulin

• Ontuxizumab

• Oprozomib

• Oregovomab

• P

• Palbociclib

• Patritumab

• Polmacoxib

• Pritumumab

• S

• Saracatinib

• Seribantumab

• Selumetinib

• Solitomab

• T

• Talazoparib

• Tarextumab

• Teprotumumab

• Tivozanib

• V

• Vatalanib also update PARP inhibitor

Updated
{{columns-list|colwidth=22em|

A–D

 * Abexinostat
 * Acivicin
 * Adecatumumab
 * ANG1005
 * Anatumomab mafenatox
 * Apolizumab
 * Alisertib
 * Apricoxib
 * Canertinib
 * Cantuzumab mertansine
 * Cediranib
 * Cixutumumab
 * Cobimetinib
 * Conatumumab
 * Copanlisib
 * Daratumumab
 * Dinaciclib
 * Drozitumab
 * Duligotuzumab
 * Duvelisib

E–L

 * Ensituximab
 * EPI-001
 * EPI-506
 * Etalocib
 * Flanvotumab
 * Foretinib
 * Girentuximab
 * Glembatumumab vedotin
 * Imalumab
 * Intetumumab
 * Iratumumab
 * Isatuximab
 * Lexatumumab
 * Linsitinib
 * Lumiliximab

M-R

 * Mapatumumab
 * Margetuximab
 * Mitumomab
 * Motesanib
 * Obatoclax
 * OX1001
 * PAC-1
 * Pacritinib
 * Panitumumab
 * Quisinostat
 * Radretumab
 * Rebeccamycin
 * Reolysin
 * Rigosertib
 * Robatumumab

S-Z
}}
 * Sacituzumab govitecan
 * Sonidegib
 * Tovetumab
 * Tivantinib
 * Ubenimex
 * Urelumab
 * Vantictumab
 * Veliparib
 * Volasertib
 * ZD6126
 * Zibotentan
 * Zoptarelin doxorubicin
 * Zosuquidar

Non -mab/-ibs
• 6-Diazo-5-oxo-L-norleucine

• Acridine carboxamide

• Adozelesin

• Allovectin-7

• Amonafide

• Artemisinin

• Atiprimod

• Atrasentan

• Bropirimine

• Brostallicin

• Bryostatin

• Cilengitide

• Combretastatin A-4

• Combretastatin A-4 phosphate

• CRLX101

• Cryptolepine

• DHA-paclitaxel

• Dichloroacetic acid

• Discodermolide

• Entolimod

• Erbulozole

• Ethynylandrostanediol

• Evofosfamide

• Ferruginol

• Forodesine

• Galeterone

• Glufosfamide

• GVAX

• Imexon

• IMP321

• Indolocarbazole

• Irofulven

• Laniquidar

• Mafosfamide

• Maytansinoid

• Mertansine

• MK-2206

• NAMI-A

• Navitoclax

• Neocarzinostatin

• NK012

• O6-Benzylguanine

• Oblimersen

• Panobinostat *

• Plinabulin

• Plitidepsin

• Prinomastat

• Salinosporamide A

• Seviteronel

• Sparsomycin

• Sulforaphane

• Swainsonine

• Tanespimycin

• Tariquidar

• TAS-108

• Tasquinimod

• Tiazofurin

• Tilomisole

• Tirapazamine

• Troxacitabine

• Valspodar

• Venetoclax *

• Vintafolide